AI assistant
SURMODICS INC — Director's Dealing 2019
Nov 5, 2019
32845_dirs_2019-11-05_546e0c00-7e0c-4416-becf-40a77d3a121b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2019-11-01
Reporting Person: Maharaj Gary R (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-01 | Common Stock | S | 4500 | $40.5152 | Disposed | 128153 | Direct |
| 2019-11-01 | Common Stock | S | 500 | $41.288 | Disposed | 127653 | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019.
F2: Reflects the weighted average price of 4,500 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 1, 2019 with sale prices ranging from $39.95 to $40.94 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Reflects the weighted average price of 500 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 1, 2019 with sale prices ranging from $40.96 to $41.77 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.